Login / Signup

Immunosuppressive therapy in elderly patients with neuromyelitis optica spectrum disorder: a retrospective multicentre study.

Ki Hoon KimYeon Hak ChungJu-Hong MinHee Jo HanSeung Woo KimHa Young ShinYoung Nam KwonSung-Min KimYoung-Min LimHyunjin KimEun-Jae LeeSeong Ho JeongJae-Won HyunSu-Hyun KimHo Jin Kim
Published in: Journal of neurology, neurosurgery, and psychiatry (2024)
In elderly patients with NMOSD, IST offers potential benefits in reducing relapse rates alongside a tolerable risk of adverse events.
Keyphrases
  • spectrum disorder
  • stem cells
  • human health
  • risk assessment
  • mesenchymal stem cells
  • cell therapy